XML 17 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash Flows from Operating Activities    
Net loss $ (8,988,402) $ (3,690,345)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization expense 503,384 385
Bad debt expense 12,000 16,000
Equity based compensation expense 2,646,013 2,979,592
Recognized loss on marketable securities 20,259 119,854
Expenses paid through financings 32,500 15,000
Loan principal paid directly through grant (8,853)
Amortization of debt discount and debt costs 1,029,882 32,522
Initial derivative expense 3,340,554
Change in derivative value due to anti-dilution adjustments 2,642,175
Change in fair value of derivative liability (3,306,350) (968,898)
Changes in operating assets and liabilities:    
Decrease in accounts receivable 126,492 140,912
(Increase) decrease in prepaid expenses and other current assets 25,950 (147,162)
Increase (decrease) in accounts payable and accrued liabilities (68,633) 916,400
Increase in other liabilities 132,950
Decrease in deferred revenue (66,497) (17,644)
Net cash used in operating activities (1,926,576) (603,384)
Cash Flows from Investing Activities    
Proceeds from sale of marketable securities 17,009 68,703
Cash paid for customer contracts (50,000)
Cash paid for equipment (3,463)
Cash paid for software development (11,500)
Net cash provided (used) by investing activities (32,991) 53,740
Cash Flows from Financing Activities    
Proceeds from notes 398,545 45,005
Proceeds from convertible notes 2,226,000
Payments of notes (11,155) (98,775)
Advances on receivables 180,778
Repayments of advances on receivables (180,778)
Repayments of sale of future revenues (403,617)
Deposit on purchase of preferred stock 500,000
Repayment of deposit on purchase of preferred stock (215,000)
Proceeds from sale of preferred stock 25,000 979,997
Net cash provided by financing activities 2,234,773 1,211,227
Net increase in cash 275,206 661,583
Cash, beginning of period 306,252 14,152
Cash, end of period 581,458 675,735
Supplemental disclosures of cash flow information:    
Cash paid during the period for interest 128,979 35,035
Cash paid during the period for income taxes
Supplemental schedule of non-cash investing and financing activities:    
Original issue discount deducted from convertible note proceeds 328,125
Debt costs deducted from convertible note proceeds 366,500
Preferred stock issued for accrued penalties 1,929,516
Preferred stock issued for asset acquisition 8,600,000
Non-cash adjustments to Redeemable Preferred Stock of subsidiary 2,059,764
Notes payable and accrued interest exchanged for preferred stock 116,380
Accounts payable paid through proceeds of preferred stock 100,000
Accrued compensation paid with common stock 56,250
Value of warrant issued with note 42,000
Accounts payable paid through proceeds of note 4,995
Warrant derivative liability at inception 2,284,965 1,750,646
Accrued compensation forgiven and credited to contributed capital 187,500
Marketable securities received as payment for Series D preferred stock 240,000
Notes and accrued interest forgiven $ 706,502